Clinical trial · Interventional
Impact of Homeopathy for Persistent Insomnia in Patients With Cancer
Randomized Controlled Trial of Homeopathy Compared With Treatment As Usual for Persistent Insomnia in Patients With Cancer
NCT02515006CI-TRIAL-00018744completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Persistent insomnia is highly prevalent complaint in cancer survivors, but is seldom satisfactorily addressed. The adaptation to cancer care of a validated, cost-effective intervention may offer a practicable solution. The aim of this study was to investigate the clinical effectiveness of homeopathy for insomnia.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Chronic Insomnia | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Homeopathy Medicine | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Homeopathy
- description
- Individualized homeopathy treatment as a supportive care
- interventionNames
- Other: Homeopathy Medicine
- type
- NO_INTERVENTION
- label
- Control
- description
- Usual Care
Primary outcomes (1)
- measure
- Changes in sleep efficiency on the Insomnia Severity Index
- timeFrame
- From baseline to 6 Months
Secondary outcomes (2)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 45 Years
Show eligibility criteria text
Inclusion Criteria: * scheduled to begin chemotherapy or radiotherapy * chemotherapy or radiotherapy * meet diagnostic criteria for chronic insomnia (i.e., lasting for at least one month) * Chronic insomnia has been defined in previous research:as the presence of (1) three or more episodes of insomnia (i.e., ≥ 30minuteSOL, ≥ 60minute wake after sleep onset (WASO), or ≤ 6.5 hour total sleep time (TST) per night) of per week and (2) daytime effects of insomnia, such as irritability, difficulty concentrating, or fatigue for at least one month. * have the permission of their oncologists to participate. Exclusion Criteria: * untreated alcohol or substance abuse or dependence, * bipolar, or psychotic disordermedical conditions such as seizure disorder, restless leg disorder, or Parkinson's disease * untreated sleep disorders such as sleep apnea * Taking other alternative medicines
References
Publications (0)
Data not yet available
No reference posted for this study.